Cargando…
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
BACKGROUND: In clinical practice, physicians often need to change the antipsychotic medications they give to patients because of an inadequate response or the presence of unacceptable or unsafe side effects. However, there is a lack of consensus in the field as to the optimal switching strategy for...
Autores principales: | Ganguli, Rohan, Brar, Jaspreet S, Mahmoud, Ramy, Berry, Sally A, Pandina, Gahan J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474645/ https://www.ncbi.nlm.nih.gov/pubmed/18590519 http://dx.doi.org/10.1186/1741-7015-6-17 |
Ejemplares similares
-
An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012) -
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
por: Gianfrancesco, Frank D, et al.
Publicado: (2009) -
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010) -
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
por: Pandina, Gahan J, et al.
Publicado: (2007) -
Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: A prospective open label observational study
por: Choure, Balwant Kisanrao, et al.
Publicado: (2014)